To examine the association of the signature with the clinicopathological characteristics of CRC, we determined the correlation between the signature and different clinical characteristics of CRC (age, sex, tumor location, TNM stage, KRAS mutation, and BRAF mutation). This evidence concerns the gene KRAS and colorectal carcinoma.